U.S. Communications Stock News

If you are wondering whether Universal Health Services is attractively priced or starting to look expensive, you are in the right place for a clear look at what the market might be implying about its value. The shares last closed at US$206.10, with returns of a 10.6% decline over 7 days, 1.5% over 30 days, a 6.3% decline year to date, 18.1% over 1 year, 64.2% over 3 years, and 61.1% over 5 years. This gives you a broad sense of how sentiment around the stock has shifted over time. Recent...

ON Semiconductor is sharpening its focus on higher margin areas, including silicon carbide products and AI data center power solutions. The company is reallocating capital toward projects it views as higher return and scaling back exposure to weaker end markets such as electric vehicles and smartphones. Management is emphasizing capital discipline and targeted investment as it reshapes the business mix of NasdaqGS:ON. For investors tracking NasdaqGS:ON, this reset comes with the stock...

Coastal Financial recently reported a past-quarter update showing a 1.3% year-on-year revenue decline, missing analysts’ expectations by 16.6%, even as loans receivable grew 1.2% and deposits rose 4.3%. Management emphasized the potential of its Banking-as-a-Service platform, highlighting plans to expand product offerings and scale new and existing partnerships despite the disappointing revenue and net interest income performance. We’ll now examine how Coastal Financial’s revenue shortfall...

Vera Therapeutics reported full-year 2025 results showing a net loss of US$299.62 million, while advancing atacicept with positive Phase 3 IgA nephropathy data and securing FDA priority review with a July 7, 2026 PDUFA date. Alongside filing a US$191.89 million Class A common stock shelf registration for an ESOP-related offering, the company highlighted that its cash, equivalents, marketable securities and debt facility availability are expected to fund operations through potential atacicept...

The Honest Company, Inc. recently reported that full-year 2025 sales slipped to US$371.32 million while net loss more than doubled to US$15.69 million, and simultaneously announced a new US$25 million share repurchase program funded by cash on hand and operating cash flows. Alongside this, management issued 2026 guidance calling for an anticipated high-teens percentage decline in reported revenue due to exited categories, while emphasizing 4% to 6% organic growth as the core metric of its...

If you are wondering whether Evercore's current share price fairly reflects its underlying worth, you are not alone. This article is designed to help you size that up clearly. The stock last closed at US$308.84, with returns of 29.2% over 1 year and a 144.5% gain over 3 years, even though the past 7 days and 30 days show declines of 5.9% and 15.0% and the year to date return sits at a 12.1% decline. Recent coverage has focused on Evercore's role as a major independent investment bank in...

If you are wondering whether Vistance Networks at around US$17.57 still offers value after a strong run, this article will help you size up the price against the fundamentals. The stock has pulled back with a 7.4% decline over the last week and a 6.5% decline over the last 30 days, yet it still sits on a 176.7% return over the past year and 125.3% over three years. Recent price moves come as the market continues to react to ongoing news flow around Vistance Networks, including growing...

Enact Holdings, Inc. has recently outlined in its 2025 10-K a new US$350 million share repurchase authorization and a US$435 million revolving credit facility, alongside continued plans to return capital via dividends and buybacks while supporting its U.S. mortgage insurance operations. Analyst sentiment has shifted as Enact was elevated to a Zacks Rank #1 (Strong Buy) on the back of higher earnings estimates, underscoring how its capital return plans and financing flexibility are...

In late February 2026, Marsh & McLennan Companies’ board declared a US$0.900 quarterly dividend per share and secured a court injunction protecting its confidential information, while also adding experienced investment executive Peter Harrison to its now 13‑member board. Together, the legal victory, board refresh, and continued capital return program underscore how Marsh & McLennan is reinforcing both its governance framework and protection of core client and data relationships. We’ll now...

Albertsons Companies (NYSE:ACI) has appointed experienced technology executive Brian Rice to its Board of Directors. Rice brings a background in digital transformation, technology leadership, and global supply chain operations at major consumer brands including McDonald's. The board change highlights a focus on technology, digital engagement, and cybersecurity for the grocery retailer. Albertsons, one of the largest food and drug retailers in the United States, operates a wide network of...

Nordson (NasdaqGS:NDSN) reported strong Q1 earnings, followed by several analyst upgrades. Shortly after these results, the CEO and Executive Vice President executed significant insider share sales. The timing of these transactions, coming on the heels of upbeat quarterly news, has drawn investor attention. Nordson, a producer of precision dispensing and related technologies, operates at the intersection of industrial, electronics, and consumer end markets. Many of its customers use Nordson...

Nordic American Tankers (NAT) has rounded out FY 2025 with Q4 revenue of US$59.5 million and net income of US$11.7 million, equal to EPS of about US$0.06, against a trailing 12 month EPS figure of roughly US$0.06 on revenue of US$183.3 million. The company has recorded quarterly revenue between US$37.9 million and US$59.5 million over 2025, while EPS has ranged from a small loss of about US$0.01 to a gain of roughly US$0.06. This has set up a results season in which investors are paying close...

In recent months, Viking Therapeutics has advanced its dual GLP-1/GIP obesity candidate VK2735 into late-stage trials while a rival program, Novo Nordisk’s CagriSema, missed a key goal in late-stage testing. This combination of competitor setbacks and Viking’s progress, including plans for both injectable and oral VK2735 formulations, has sharpened investor focus on the company’s role in the obesity treatment race. With VK2735 moving into phase 3 trials, we’ll now examine how this...

MARA Holdings, NasdaqCM:MARA, is shifting its core business from Bitcoin mining to AI and high performance computing infrastructure. The company has entered a joint venture with Starwood Capital Group and Starwood Digital Ventures to convert and expand its existing power heavy sites. The partnership also includes acquiring a majority stake in Exaion to support international data center expansion. MARA Holdings is moving away from a pure Bitcoin mining model and into digital infrastructure...

Cleveland-Cliffs recently appointed Ralph “Mike” Michael III as Lead Independent Director and named Edilson Camara Chairman of the Compensation and Organization Committee, following Douglas Taylor’s resignation under the company’s mandatory resignation policy tied to changes in a director’s primary occupation. With a seasoned leadership advisor now guiding compensation decisions and an experienced independent director leading the board, Cleveland-Cliffs is reinforcing its governance...

Ardagh Metal Packaging S.A. recently reported its fourth-quarter and full-year 2025 results, with full-year sales rising to US$5,497 million from US$4,908 million, net income improving to US$11 million from a net loss of US$3 million, and its board approving a quarterly interim dividend of US$0.10 per share payable on March 26, 2026. Beneath these headline numbers, the company delivered a 10% increase in adjusted EBITDA, grew shipments by over 3%, raised US$1.30 billion in green bonds, and...

Financial results snapshot Baldwin Insurance Group (BWIN) just wrapped up FY 2025 with Q4 revenue of US$347.3 million and a basic EPS loss of US$0.37, alongside trailing twelve month revenue of about US$1.5 billion and a full year basic EPS loss of US$0.50. The company has seen quarterly revenue move from US$329.9 million in Q4 2024 to US$347.3 million in Q4 2025, while basic EPS over the same quarters went from a loss of US$0.31 to a loss of US$0.37. This has set up a results season where...

StoneX Group’s StoneX Digital division recently launched a digital asset lending capability, adding Bitcoin-backed lending to its existing institutional brokerage, execution, and financing services within a single framework. This move highlights StoneX’s effort to integrate digital asset lending into established collateral management and risk controls, targeting institutional clients seeking liquidity and capital efficiency without exiting their crypto exposure. We’ll now examine how the...

Wondering if Par Pacific Holdings at around US$42.67 is offering genuine value or if the excitement has already been priced in? This article walks through what the numbers are really saying about the stock. The share price return profile is mixed in the short term, with a 0.2% decline over 7 days, a 17.7% gain over 30 days, a 19.1% gain year to date and a 196.9% gain over the past year, along with 43.1% and 130.6% returns over 3 and 5 years. Recent news coverage has focused on Par Pacific...

Wondering if Peoples Bancorp at around US$32.27 is giving you fair value for your money, or if the market is mispricing this regional bank? The stock has seen mixed short term moves, with a 5.2% decline over the last 7 days, a 2.6% return over 30 days, and returns of 7.0% year to date, 6.6% over 1 year, 23.2% over 3 years and 26.2% over 5 years that some investors may view as a reset in expectations. Recent news coverage around Peoples Bancorp has focused on its positioning within the U.S...

If you are wondering whether Zebra Technologies at around US$223.96 is starting to look like value, you are not alone. This article is geared to help you frame that question clearly. The shares have seen a 12.3% decline over the last 7 days, a 5.2% decline over 30 days, and are down 9.8% year to date and 28.9% over the past year, with a 27.6% decline over 3 years and 53.2% over 5 years. Recent news coverage around Zebra has focused on its role in barcode, data capture, and automation...

Why Sidus Space is in Focus After Its $100 Million Equity Offering Filing Sidus Space (SIDU) has drawn fresh attention after filing for a follow on equity offering of up to US$100 million in Class A common stock, structured as an at the market program. This type of offering can influence Sidus Space’s capital structure and funding flexibility. As a result, investors may reassess how the stock’s recent performance and risk profile fit within their broader portfolios. See our latest analysis...

NuScale Power (SMR) has wrapped up FY 2025 with fourth quarter revenue of US$1.8 million and a basic EPS loss of US$0.16, alongside a trailing twelve month EPS loss of US$2.17 on revenue of US$31.5 million and a net income loss of US$355.8 million. Over the past six quarters, the company has seen quarterly revenue range from US$0.5 million to US$34.2 million, while basic EPS has moved between a loss of US$0.11 and a loss of US$1.95. This gives investors a data-heavy view of how top line...

MetLife stock performance snapshot MetLife (MET) shares recently closed at US$72.07, with the stock showing a 5.1% decline over the past day and an 8.9% decline over the past week, putting recent performance in focus for investors. See our latest analysis for MetLife. The recent 5.1% 1 day and 8.9% 7 day share price declines sit within a broader pattern of weaker momentum, with the year to date share price return at 10.3% and the 1 year total shareholder return at 13.9% in the red, despite 3...